As of Aug 23
| -0.14 / -0.84%|
The 10 analysts offering 12-month price forecasts for Takeda Pharmaceutical Co Ltd have a median target of 24.47, with a high estimate of 29.12 and a low estimate of 17.48. The median estimate represents a +48.65% increase from the last price of 16.46.
The current consensus among 11 polled investment analysts is to Buy stock in Takeda Pharmaceutical Co Ltd. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.